Table of Contents Author Guidelines Submit a Manuscript
Stem Cells International
Volume 2011, Article ID 383709, 12 pages
http://dx.doi.org/10.4061/2011/383709
Review Article

Cardiac Differentiation of Pluripotent Stem Cells

1Regea - Institute for Regenerative Medicine, University of Tampere, Tampere University Hospital, 33520 Tampere, Finland
2Heart Center, Tampere University Hospital, 33520 Tampere, Finland

Received 16 November 2010; Revised 1 February 2011; Accepted 8 February 2011

Academic Editor: Steve Oh

Copyright © 2011 Kristiina Rajala et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. T. Meyer, P. Sartipy, F. Blind, C. Leisgen, and E. Guenther, “New cell models and assays in cardiac safety profiling,” Expert Opinion on Drug Metabolism and Toxicology, vol. 3, no. 4, pp. 507–517, 2007. View at Publisher · View at Google Scholar · View at Scopus
  2. S. Dimmeler, J. Burchfield, and A. M. Zeiher, “Cell-based therapy of myocardial infarction,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 28, no. 2, pp. 208–216, 2008. View at Publisher · View at Google Scholar · View at Scopus
  3. C. E. Murry, L. J. Field, and P. Menasché, “Cell-based cardiac repair reflections at the 10-year point,” Circulation, vol. 112, no. 20, pp. 3174–3183, 2005. View at Publisher · View at Google Scholar · View at Scopus
  4. P. Anversa, A. Leri, M. Rota et al., “Concise review: stem cells, myocardial regeneration, and methodological artifacts,” Stem Cells, vol. 25, no. 3, pp. 589–601, 2007. View at Publisher · View at Google Scholar · View at Scopus
  5. G. Blin, D. Nury, S. Stefanovic et al., “A purified population of multipotent cardiovascular progenitors derived from primate pluripotent stem cells engrafts in postmyocardial infarcted nonhuman primates,” Journal of Clinical Investigation, vol. 120, no. 4, pp. 1125–1139, 2010. View at Publisher · View at Google Scholar · View at Scopus
  6. I. Kehat, D. Kenyagin-Karsenti, M. Snir et al., “Human embryonic stem cells can differentiate into myocytes with structural and functional properties of cardiomyocytes,” Journal of Clinical Investigation, vol. 108, no. 3, pp. 407–414, 2001. View at Publisher · View at Google Scholar · View at Scopus
  7. C. Xu, S. Police, N. Rao, and M. K. Carpenter, “Characterization and enrichment of cardiomyocytes derived from human embryonic stem cells,” Circulation Research, vol. 91, no. 6, pp. 501–508, 2002. View at Publisher · View at Google Scholar · View at Scopus
  8. J. Q. He, Y. Ma, Y. Lee, J. A. Thomson, and T. J. Kamp, “Human embryonic stem cells develop into multiple types of cardiac myocytes: action potential characterization,” Circulation Research, vol. 93, no. 1, pp. 32–39, 2003. View at Publisher · View at Google Scholar · View at Scopus
  9. C. Mummery, D. Ward-van Oostwaard, P. Doevendans et al., “Differentiation of human embryonic stem cells to cardiomyocytes: role of coculture with visceral endoderm-like cells,” Circulation, vol. 107, no. 21, pp. 2733–2740, 2003. View at Google Scholar · View at Scopus
  10. C. Améen, R. Strehl, P. Björquist, A. Lindahl, J. Hyllner, and P. Sartipy, “Human embryonic stem cells: current technologies and emerging industrial applications,” Critical Reviews in Oncology/Hematology, vol. 65, no. 1, pp. 54–80, 2008. View at Publisher · View at Google Scholar · View at Scopus
  11. J. A. Thomson, “Embryonic stem cell lines derived from human blastocysts,” Science, vol. 282, no. 5391, pp. 1145–1147, 1998. View at Google Scholar · View at Scopus
  12. J. Zhang, G. F. Wilson, A. G. Soerens et al., “Functional cardiomyocytes derived from human induced pluripotent stem cells,” Circulation Research, vol. 104, no. 4, pp. e30–e41, 2009. View at Publisher · View at Google Scholar · View at Scopus
  13. L. Zwi, O. Caspi, G. Arbel et al., “Cardiomyocyte differentiation of human induced pluripotent stem cells,” Circulation, vol. 120, no. 15, pp. 1513–1523, 2009. View at Publisher · View at Google Scholar · View at Scopus
  14. A. Haase, R. Olmer, K. Schwanke et al., “Generation of induced pluripotent stem cells from human cord blood,” Cell Stem Cell, vol. 5, no. 4, pp. 434–441, 2009. View at Publisher · View at Google Scholar · View at Scopus
  15. H. Vidarsson, J. Hyllner, and P. Sartipy, “Differentiation of human embryonic stem cells to cardiomyocytes for in vitro and in vivo applications,” Stem Cell Reviews and Reports, vol. 6, no. 1, pp. 108–120, 2010. View at Publisher · View at Google Scholar · View at Scopus
  16. S. R. Braam, R. Passier, and C. L. Mummery, “Cardiomyocytes from human pluripotent stem cells in regenerative medicine and drug discovery,” Trends in Pharmacological Sciences, vol. 30, no. 10, pp. 536–545, 2009. View at Publisher · View at Google Scholar · View at Scopus
  17. K. Takahashi, K. Tanabe, M. Ohnuki et al., “Induction of pluripotent stem cells from adult human fibroblasts by defined factors,” Cell, vol. 131, no. 5, pp. 861–872, 2007. View at Publisher · View at Google Scholar · View at Scopus
  18. J. Yu, M. A. Vodyanik, K. Smuga-Otto et al., “Induced pluripotent stem cell lines derived from human somatic cells,” Science, vol. 318, no. 5858, pp. 1917–1920, 2007. View at Publisher · View at Google Scholar · View at Scopus
  19. I. Itzhaki, L. Maizels, I. Huber et al., “Modelling the long QT syndrome with induced pluripotent stem cells,” Nature, vol. 471, no. 7337, pp. 225–229, 2011. View at Google Scholar
  20. A. Moretti, M. Bellin, A. Welling et al., “Patient-specific induced pluripotent stem-cell models for long-QT syndrome,” New England Journal of Medicine, vol. 363, no. 15, pp. 1397–1409, 2010. View at Publisher · View at Google Scholar
  21. I. Kehat, L. Khimovich, O. Caspi et al., “Electromechanical integration of cardiomyocytes derived from human embryonic stem cells,” Nature Biotechnology, vol. 22, no. 10, pp. 1282–1289, 2004. View at Publisher · View at Google Scholar · View at Scopus
  22. M. A. Laflamme, J. Gold, C. Xu et al., “Formation of human myocardium in the rat heart from human embryonic stem cells,” American Journal of Pathology, vol. 167, no. 3, pp. 663–671, 2005. View at Google Scholar · View at Scopus
  23. J. Leor, S. Gerecht, S. Cohen et al., “Human embryonic stem cell transplantation to repair the infarcted myocardium,” Heart, vol. 93, no. 10, pp. 1278–1284, 2007. View at Publisher · View at Google Scholar · View at Scopus
  24. O. Caspi, I. Huber, I. Kehat et al., “Transplantation of human embryonic stem cell-derived cardiomyocytes improves myocardial performance in infarcted rat hearts,” Journal of the American College of Cardiology, vol. 50, no. 19, pp. 1884–1893, 2007. View at Publisher · View at Google Scholar · View at Scopus
  25. L. W. van Laake, R. Passier, J. Monshouwer-Kloots et al., “Human embryonic stem cell-derived cardiomyocytes survive and mature in the mouse heart and transiently improve function after myocardial infarction,” Stem Cell Research, vol. 1, no. 1, pp. 9–24, 2007. View at Publisher · View at Google Scholar · View at Scopus
  26. W. Dai, L. J. Field, M. Rubart et al., “Survival and maturation of human embryonic stem cell-derived cardiomyocytes in rat hearts,” Journal of Molecular and Cellular Cardiology, vol. 43, no. 4, pp. 504–516, 2007. View at Publisher · View at Google Scholar · View at Scopus
  27. M. A. Laflamme, K. Y. Chen, A. V. Naumova et al., “Cardiomyocytes derived from human embryonic stem cells in pro-survival factors enhance function of infarcted rat hearts,” Nature Biotechnology, vol. 25, no. 9, pp. 1015–1024, 2007. View at Publisher · View at Google Scholar · View at Scopus
  28. T. J. Nelson, A. Martinez-Fernandez, S. Yamada, C. Perez-Terzic, Y. Ikeda, and A. Terzic, “Repair of acute myocardial infarction with induced pluripotent stem cells induced by human stemness factors,” Circulation, vol. 120, no. 5, pp. 408–416, 2009. View at Publisher · View at Google Scholar · View at Scopus
  29. F. F. Yi, L. Yang, Y. H. Li, PI. X. Su, J. Cai, and X. C. Yang, “Electrophysiological development of transplanted embryonic stem cell-derived cardiomyocytes in the hearts of syngeneic mice,” Archives of Medical Research, vol. 40, no. 5, pp. 339–344, 2009. View at Publisher · View at Google Scholar · View at Scopus
  30. Y. M. Zhang, C. Hartzell, M. Narlow, and S. C. Dudley Jr., “Stem cell-derived cardiomyocytes demonstrate arrhythmic potential,” Circulation, vol. 106, no. 10, pp. 1294–1299, 2002. View at Publisher · View at Google Scholar · View at Scopus
  31. D. Srivastava and K. N. Ivey, “Potential of stem-cell-based therapies for heart disease,” Nature, vol. 441, no. 7097, pp. 1097–1099, 2006. View at Publisher · View at Google Scholar · View at Scopus
  32. Y. Hiroi, S. Kudoh, K. Monzen et al., “Tbx5 associates with Nkx2-5 and synergistically promotes cardiomyocyte differentiation,” Nature Genetics, vol. 28, no. 3, pp. 276–280, 2001. View at Publisher · View at Google Scholar · View at Scopus
  33. T. Peterkin, A. Gibson, and R. Patient, “GATA-6 maintains BMP-4 and Nkx2 expression during cardiomyocyte precursor maturation,” EMBO Journal, vol. 22, no. 16, pp. 4260–4273, 2003. View at Publisher · View at Google Scholar · View at Scopus
  34. T. F. Plageman Jr. and K. E. Yutzey, “Differential expression and function of Tbx5 and Tbx20 in cardiac development,” Journal of Biological Chemistry, vol. 279, no. 18, pp. 19026–19034, 2004. View at Publisher · View at Google Scholar
  35. P. Riley, L. Anson-Cartwright, and J. C. Cross, “The Hand1 bHLH transcription factor is essential for placentation and cardiac morphogenesis,” Nature Genetics, vol. 18, no. 3, pp. 271–275, 1998. View at Publisher · View at Google Scholar · View at Scopus
  36. A. J. Watt, M. A. Battle, J. Li, and S. A. Duncan, “GATA4 is essential for formation of the proepicardium and regulates cardiogenesis,” Proceedings of the National Academy of Sciences of the United States of America, vol. 101, no. 34, pp. 12573–12578, 2004. View at Publisher · View at Google Scholar · View at Scopus
  37. A. Bondue, G. Lapouge, C. Paulissen et al., “Mesp1 acts as a master regulator of multipotent cardiovascular progenitor specification,” Cell stem cell, vol. 3, no. 1, pp. 69–84, 2008. View at Publisher · View at Google Scholar · View at Scopus
  38. R. C. Lindsley, J. G. Gill, T. L. Murphy et al., “Mesp1 coordinately regulates cardiovascular fate restriction and epithelial-mesenchymal transition in differentiating ESCs,” Cell stem cell, vol. 3, no. 1, pp. 55–68, 2008. View at Publisher · View at Google Scholar · View at Scopus
  39. M. J. Marvin, G. Di Rocco, A. Gardiner, S. M. Bush, and A. B. Lassar, “Inhibition of Wnt activity induces heart formation from posterior mesoderm,” Genes and Development, vol. 15, no. 3, pp. 316–327, 2001. View at Publisher · View at Google Scholar · View at Scopus
  40. T. Mima, H. Ueno, D. A. Fischman, L. T. Williams, and T. Mikawa, “Fibroblast growth factor receptor is required for in vivo cardiac myocyte proliferation at early embryonic stages of heart development,” Proceedings of the National Academy of Sciences of the United States of America, vol. 92, no. 2, pp. 467–471, 1995. View at Publisher · View at Google Scholar
  41. G. Winnier, M. Blessing, P. A. Labosky, and B. L. M. Hogan, “Bone morphogenetic protein-4 is required for mesoderm formation and patterning in the mouse,” Genes and Development, vol. 9, no. 17, pp. 2105–2116, 1995. View at Google Scholar · View at Scopus
  42. H. Zhang and A. Bradley, “Mice deficient for BMP2 are nonviable and have defects in amnion/chorion and cardiac development,” Development, vol. 122, no. 10, pp. 2977–2986, 1996. View at Google Scholar · View at Scopus
  43. A. E. Pasquinelli, S. Hunter, and J. Bracht, “MicroRNAs: a developing story,” Current Opinion in Genetics and Development, vol. 15, no. 2, pp. 200–205, 2005. View at Publisher · View at Google Scholar · View at Scopus
  44. Y. Zhao and D. Srivastava, “A developmental view of microRNA function,” Trends in Biochemical Sciences, vol. 32, no. 4, pp. 189–197, 2007. View at Publisher · View at Google Scholar · View at Scopus
  45. T. E. Callis, Z. Deng, J. F. Chen, and DA. Z. Wang, “Muscling through the microRNA world,” Experimental Biology and Medicine, vol. 233, no. 2, pp. 131–138, 2008. View at Publisher · View at Google Scholar · View at Scopus
  46. E. van Rooij, N. Liu, and E. N. Olson, “MicroRNAs flex their muscles,” Trends in Genetics, vol. 24, no. 4, pp. 159–166, 2008. View at Publisher · View at Google Scholar · View at Scopus
  47. Z. Wang, X. Luo, Y. Lu, and B. Yang, “miRNAs at the heart of the matter,” Journal of Molecular Medicine, vol. 86, no. 7, pp. 771–783, 2008. View at Publisher · View at Google Scholar · View at Scopus
  48. K. N. Ivey, A. Muth, J. Arnold et al., “MicroRNA regulation of cell lineages in mouse and human embryonic stem cells,” Cell Stem Cell, vol. 2, no. 3, pp. 219–229, 2008. View at Publisher · View at Google Scholar · View at Scopus
  49. D. Nury, T. Neri, and M. Pucéat, “Human embryonic stem cells and cardiac cell fate,” Journal of Cellular Physiology, vol. 218, no. 3, pp. 455–459, 2009. View at Publisher · View at Google Scholar · View at Scopus
  50. P. Gadue, T. L. Huber, P. J. Paddison, and G. M. Keller, “Wnt and TGF-β signaling are required for the induction of an in vitro model of primitive streak formation using embryonic stem cells,” Proceedings of the National Academy of Sciences of the United States of America, vol. 103, no. 45, pp. 16806–16811, 2006. View at Publisher · View at Google Scholar · View at Scopus
  51. R. C. Lindsley, J. G. Gill, M. Kyba, T. L. Murphy, and K. M. Murphy, “Canonical Wnt signaling is required for development of embryonic stem cell-derived mesoderm,” Development, vol. 133, no. 19, pp. 3787–3796, 2006. View at Publisher · View at Google Scholar · View at Scopus
  52. A. C. Foley, O. Korol, A. M. Timmer, and M. Mercola, “Multiple functions of Cerberus cooperate to induce heart downstream of Nodal,” Developmental Biology, vol. 303, no. 1, pp. 57–65, 2007. View at Publisher · View at Google Scholar · View at Scopus
  53. A. C. Foley and M. Mercola, “Heart induction by Wnt antagonists depends on the homeodomain transcription factor Hex,” Genes and Development, vol. 19, no. 3, pp. 387–396, 2005. View at Publisher · View at Google Scholar · View at Scopus
  54. V. A. Schneider and M. Mercola, “Wnt antagonism initiates cardiogenesis in Xenopus laevis,” Genes and Development, vol. 15, no. 3, pp. 304–315, 2001. View at Publisher · View at Google Scholar · View at Scopus
  55. A. T. Naito, I. Shiojima, H. Akazawa et al., “Developmental stage-specific biphasic roles of Wnt/β-catenin signaling in cardiomyogenesis and hematopoiesis,” Proceedings of the National Academy of Sciences of the United States of America, vol. 103, no. 52, pp. 19812–19817, 2006. View at Publisher · View at Google Scholar · View at Scopus
  56. S. Ueno, G. Weidinger, T. Osugi et al., “Biphasic role for Wnt/β-catenin signaling in cardiac specification in zebrafish and embryonic stem cells,” Proceedings of the National Academy of Sciences of the United States of America, vol. 104, no. 23, pp. 9685–9690, 2007. View at Publisher · View at Google Scholar · View at Scopus
  57. L. Yang, M. H. Soonpaa, E. D. Adler et al., “Human cardiovascular progenitor cells develop from a KDR+ embryonic-stem-cell-derived population,” Nature, vol. 453, no. 7194, pp. 524–528, 2008. View at Publisher · View at Google Scholar · View at Scopus
  58. V. C. Chen, R. Stull, D. Joo, X. Cheng, and G. Keller, “Notch signaling respecifies the hemangioblast to a cardiac fate,” Nature Biotechnology, vol. 26, no. 10, pp. 1169–1178, 2008. View at Publisher · View at Google Scholar · View at Scopus
  59. J. Itskovitz-Eldor, M. Schuldiner, D. Karsenti et al., “Differentiation of human embryonic stem cells into embryoid bodies compromising the three embryonic germ layers,” Molecular Medicine, vol. 6, no. 2, pp. 88–95, 2000. View at Google Scholar · View at Scopus
  60. T. H. Tran, X. Wang, C. Browne et al., “Wnt3a-induced mesoderm formation and cardiomyogenesis in human embryonic stem cells,” Stem Cells, vol. 27, no. 8, pp. 1869–1878, 2009. View at Publisher · View at Google Scholar · View at Scopus
  61. B. S. Yoon, S. J. Yoo, J. E. Lee, S. You, H. T. Lee, and H. S. Yoon, “Enhanced differentiation of human embryonic stem cells into cardiomyocytes by combining hanging drop culture and 5-azacytidine treatment,” Differentiation, vol. 74, no. 4, pp. 149–159, 2006. View at Publisher · View at Google Scholar · View at Scopus
  62. E. S. Ng, R. P. Davis, L. Azzola, E. G. Stanley, and A. G. Elefanty, “Forced aggregation of defined numbers of human embryonic stem cells into embryoid bodies fosters robust, reproducible hematopoietic differentiation,” Blood, vol. 106, no. 5, pp. 1601–1603, 2005. View at Publisher · View at Google Scholar · View at Scopus
  63. S. Niebruegge, C. L. Bauwens, R. Peerani et al., “Generation of human embryonic stem cell-derived mesoderm and cardiac cells using size-specified aggregates in an oxygen-controlled bioreactor,” Biotechnology and Bioengineering, vol. 102, no. 2, pp. 493–507, 2009. View at Publisher · View at Google Scholar · View at Scopus
  64. E. Serena, E. Figallo, N. Tandon et al., “Electrical stimulation of human embryonic stem cells: cardiac differentiation and the generation of reactive oxygen species,” Experimental Cell Research, vol. 315, no. 20, pp. 3611–3619, 2009. View at Publisher · View at Google Scholar · View at Scopus
  65. J. Synnergren, K. Åkesson, K. Dahlenborg et al., “Molecular signature of cardiomyocyte clusters derived from human embryonic stem cells,” Stem Cells, vol. 26, no. 7, pp. 1831–1840, 2008. View at Publisher · View at Google Scholar · View at Scopus
  66. F. Cao, R. A. Wagner, K. D. Wilson et al., “Transcriptional and functional profilling of human embryonic stem cell-derived cardiomyocytes,” PLoS One, vol. 3, no. 10, Article ID e3474, 2008. View at Publisher · View at Google Scholar · View at Scopus
  67. X. Q. Xu, S. Y. Soo, W. Sun, and R. Zweigerdt, “Global expression profile of highly enriched cardiomyocytes derived from human embryonic stem cells,” Stem Cells, vol. 27, no. 9, pp. 2163–2174, 2009. View at Publisher · View at Google Scholar · View at Scopus
  68. R. Passier, D. Ward-Van Oostwaard, J. Snapper et al., “Increased cardiomyocyte differentiation from human embryonic stem cells in serum-free cultures,” Stem Cells, vol. 23, no. 6, pp. 772–780, 2005. View at Publisher · View at Google Scholar · View at Scopus
  69. E. Willems, P. J. Bushway, and M. Mercola, “Natural and synthetic regulators of embryonic stem cell cardiogenesis,” Pediatric Cardiology, vol. 30, no. 5, pp. 635–642, 2009. View at Publisher · View at Google Scholar · View at Scopus
  70. C. Freund, R. P. Davis, K. Gkatzis, D. Ward-van Oostwaard, and C. L. Mummery, “The first reported generation of human induced pluripotent stem cells (iPS cells) and iPS cell-derived cardiomyocytes in the Netherlands,” Netherlands Heart Journal, vol. 18, no. 1, pp. 51–54, 2010. View at Google Scholar · View at Scopus
  71. R. Graichen, X. Xu, S. R. Braam et al., “Enhanced cardiomyogenesis of human embryonic stem cells by a small molecular inhibitor of p38 MAPK,” Differentiation, vol. 76, no. 4, pp. 357–370, 2008. View at Publisher · View at Google Scholar · View at Scopus
  72. C. Freund, D. W. V. Oostwaard, J. Monshouwer-Kloots et al., “Insulin redirects differentiation from cardiogenic mesoderm and endoderm to neuroectoderm in differentiating human embryonic stem cells,” Stem Cells, vol. 26, no. 3, pp. 724–733, 2008. View at Publisher · View at Google Scholar · View at Scopus
  73. X. Q. Xu, R. Graichen, S. Y. Soo et al., “Chemically defined medium supporting cardiomyocyte differentiation of human embryonic stem cells,” Differentiation, vol. 76, no. 9, pp. 958–970, 2008. View at Publisher · View at Google Scholar · View at Scopus
  74. Y. Kang, J. M. Nagy, J. M. Polak, and A. Mantalaris, “Proteomic characterization of the conditioned media produced by the visceral endoderm-like cell lines HepG2 and END2: toward a defined medium for the osteogenic/chondrogenic differentiation of embryonic stem cells,” Stem Cells and Development, vol. 18, no. 1, pp. 77–92, 2009. View at Publisher · View at Google Scholar · View at Scopus
  75. D. K. Arrell, N. J. Niederländer, R. S. Faustino, A. Behfar, and A. Terzic, “Cardioinductive network guiding stem cell differentiation revealed by proteomic cartography of tumor necrosis factor α-primed endodermal secretome,” Stem Cells, vol. 26, no. 2, pp. 387–400, 2008. View at Publisher · View at Google Scholar · View at Scopus
  76. T. G. Otsuji, I. Minami, Y. Kurose, K. Yamauchi, M. Tada, and N. Nakatsuji, “Progressive maturation in contracting cardiomyocytes derived from human embryonic stem cells: qualitative effects on electrophysiological responses to drugs,” Stem Cell Research, vol. 4, no. 3, pp. 201–213, 2010. View at Publisher · View at Google Scholar · View at Scopus
  77. C. Xu, S. Police, M. Hassanipour, and J. D. Gold, “Cardiac bodies: a novel culture method for enrichment of cardiomyocytes derived from human embryonic stem cells,” Stem Cells and Development, vol. 15, no. 5, pp. 631–639, 2006. View at Publisher · View at Google Scholar · View at Scopus
  78. W. Rust, T. Balakrishnan, and R. Zweigerdt, “Cardiomyocyte enrichment from human embryonic stem cell cultures by selection of ALCAM surface expression,” Regenerative Medicine, vol. 4, no. 2, pp. 225–237, 2009. View at Publisher · View at Google Scholar · View at Scopus
  79. E. Kolossov, Z. Lu, I. Drobinskaya et al., “Identification and characterization of embryonic stem cell-derived pacemaker and atrial cardiomyocytes,” FASEB Journal, vol. 19, no. 6, pp. 577–579, 2005. View at Publisher · View at Google Scholar · View at Scopus
  80. W. C. Claycomb, N. A. Lanson Jr., B. S. Stallworth et al., “HL-1 cells: a cardiac muscle cell line that contracts and retains phenotypic characteristics of the adult cardiomyocyte,” Proceedings of the National Academy of Sciences of the United States of America, vol. 95, no. 6, pp. 2979–2984, 1998. View at Publisher · View at Google Scholar · View at Scopus
  81. M. Reppel, F. Pillekamp, K. Brockmeier et al., “The electrocardiogram of human embryonic stem cell-derived cardiomyocytes,” Journal of Electrocardiology, vol. 38, no. 4, pp. 166–170, 2005. View at Publisher · View at Google Scholar · View at Scopus
  82. S. J. Kattman, T. L. Huber, and G. Keller, “Multipotent Flk-1+ cardiovascular progenitor cells give rise to the cardiomyocyte, endothelial, and vascular smooth muscle lineages,” Developmental Cell, vol. 11, no. 5, pp. 723–732, 2006. View at Publisher · View at Google Scholar · View at Scopus
  83. A. Moretti, L. Caron, A. Nakano et al., “Multipotent embryonic isl1+ progenitor cells lead to cardiac, smooth muscle, and endothelial cell diversification,” Cell, vol. 127, no. 6, pp. 1151–1165, 2006. View at Publisher · View at Google Scholar · View at Scopus
  84. L. Bu, X. Jiang, S. Martin-Puig et al., “Human ISL1 heart progenitors generate diverse multipotent cardiovascular cell lineages,” Nature, vol. 460, no. 7251, pp. 113–117, 2009. View at Publisher · View at Google Scholar · View at Scopus
  85. A. Klaus and W. Birchmeier, “Developmental signaling in myocardial progenitor cells: a comprehensive view of bmp- and wnt/β-catenin signaling,” Pediatric Cardiology, vol. 30, no. 5, pp. 609–616, 2009. View at Publisher · View at Google Scholar · View at Scopus
  86. A. Raya, C. M. Koth, D. Büscher et al., “Activation of Notch signaling pathway precedes heart regeneration in zebrafish,” Proceedings of the National Academy of Sciences of the United States of America, vol. 100, no. 1, pp. 11889–11895, 2003. View at Publisher · View at Google Scholar · View at Scopus
  87. M. S. Rones, K. A. McLaughlin, M. Raffin, and M. Mercola, “Serrate and Notch specify cell fates in the heart field by suppressing cardiomyogenesis,” Development, vol. 127, no. 17, pp. 3865–3876, 2000. View at Google Scholar · View at Scopus
  88. AI. S. Tseng, F. B. Engel, and M. Keating, “The GSK-3 inhibitor BIO promotes proliferation in mammalian cardiomyocytes,” Chemistry and Biology, vol. 13, no. 9, pp. 957–963, 2006. View at Publisher · View at Google Scholar · View at Scopus
  89. F. B. Engel, M. Schebesta, M. T. Duong et al., “p38 MAP kinase inhibition enables proliferation of adult mammalian cardiomyocytes,” Genes and Development, vol. 19, no. 10, pp. 1175–1187, 2005. View at Publisher · View at Google Scholar · View at Scopus
  90. T. C. McDevitt, M. A. Laflamme, and C. E. Murry, “Proliferation of cardiomyocytes derived from human embryonic stem cells is mediated via the IGF/PI 3-kinase/Akt signaling pathway,” Journal of Molecular and Cellular Cardiology, vol. 39, no. 6, pp. 865–873, 2005. View at Publisher · View at Google Scholar · View at Scopus
  91. F. Hattori, H. Chen, H. Yamashita et al., “Nongenetic method for purifying stem cell-derived cardiomyocytes,” Nature Methods, vol. 7, no. 1, pp. 61–66, 2010. View at Publisher · View at Google Scholar · View at Scopus
  92. J. Leschik, S. Stefanovic, B. Brinon, and M. Pucéat, “Cardiac commitment of primate embryonic stem cells,” Nature Protocols, vol. 3, no. 9, pp. 1381–1387, 2008. View at Publisher · View at Google Scholar · View at Scopus
  93. Y. Shiba, K. D. Hauch, and M. A. Laflamme, “Cardiac applications for human pluripotent stem cells,” Current Pharmaceutical Design, vol. 15, no. 24, pp. 2791–2806, 2009. View at Publisher · View at Google Scholar · View at Scopus
  94. D. Anderson, T. Self, I. R. Mellor, G. Goh, S. J. Hill, and C. Denning, “Transgenic enrichment of cardiomyocytes from human embryonic stem cells,” Molecular Therapy, vol. 15, no. 11, pp. 2027–2036, 2007. View at Publisher · View at Google Scholar · View at Scopus
  95. Q. X. Xu, R. Zweigerdt, S. Y. Soo et al., “Highly enriched cardiomyocytes from human embryonic stem cells,” Cytotherapy, vol. 10, no. 4, pp. 376–389, 2008. View at Publisher · View at Google Scholar · View at Scopus
  96. I. Huber, I. Itzhaki, O. Caspi et al., “Identification and selection of cardiomyocytes during human embryonic stem cell differentiation,” FASEB Journal, vol. 21, no. 10, pp. 2551–2563, 2007. View at Publisher · View at Google Scholar · View at Scopus
  97. J. D. Fu, P. Jiang, S. Rushing, J. Liu, N. Chiamvimonvat, and R. A. Li, “Na+/Ca2+ exchanger is a determinant of excitation-contraction coupling in human embryonic stem cell-derived ventricular cardiomyocytes,” Stem Cells and Development, vol. 19, no. 6, pp. 773–782, 2010. View at Publisher · View at Google Scholar · View at Scopus
  98. H. Kita-Matsuo, M. Barcova, N. Prigozhina et al., “Lentiviral vectors and protocols for creation of stable hESC lines for fluorescent tracking and drug resistance selection of cardiomyocytes,” PLoS One, vol. 4, no. 4, Article ID e5046, 2009. View at Publisher · View at Google Scholar · View at Scopus
  99. W.-Z. Zhu, Y. Xie, K. W. Moyes, J. D. Gold, B. Askari, and M. A. Laflamme, “Neuregulin/ErbB signaling regulates cardiac subtype specification in differentiating human embryonic stem cells,” Circulation Research, vol. 107, no. 6, pp. 776–786, 2010. View at Publisher · View at Google Scholar
  100. C. Kim, M. Majdi, P. Xia et al., “Non-cardiomyocytes influence the electrophysiological maturation of human embryonic stem cell-derived cardiomyocytes during differentiation,” Stem Cells and Development, vol. 19, no. 6, pp. 783–795, 2010. View at Publisher · View at Google Scholar · View at Scopus
  101. M. Snir, I. Kehat, A. Gepstein et al., “Assessment of the ultrastructural and proliferative properties of human embryonic stem cell-derived cardiomyocytes,” American Journal of Physiology, vol. 285, no. 6, pp. H2355–H2363, 2003. View at Google Scholar · View at Scopus
  102. J. Liu, D. F. Ji, W. S. Chung, and R. A. Li, “Functional sarcoplasmic reticulum for calcium handling of human embryonic stem cell-derived cardiomyocytes: insights for driven maturation,” Stem Cells, vol. 25, no. 12, pp. 3038–3044, 2007. View at Publisher · View at Google Scholar
  103. A. Norström, K. Åkesson, T. Hardarson, L. Hamberger, P. Björquist, and P. Sartipy, “Molecular and pharmacological properties of human embryonic stem cell-derived cardiomyocytes,” Experimental Biology and Medicine, vol. 231, no. 11, pp. 1753–1762, 2006. View at Google Scholar
  104. I. Kehat, A. Gepstein, A. Spira, J. Itskovitz-Eldor, and L. Gepstein, “High-resolution electrophysiological assessment of human embryonic stem cell-derived cardiomyocytes: a novel in vitro model for the study of conduction,” Circulation Research, vol. 91, no. 8, pp. 659–661, 2002. View at Publisher · View at Google Scholar
  105. L. Sartiani, E. Bettiol, F. Stillitano, A. Mugelli, E. Cerbai, and M. E. Jaconi, “Developmental changes in cardiomyocytes differentiated from human embryonic stem cells: a molecular and electrophysiological approach,” Stem Cells, vol. 25, no. 5, pp. 1136–1144, 2007. View at Publisher · View at Google Scholar · View at Scopus
  106. K. Dolnikov, M. Shilkrut, N. Zeevi-Levin et al., “Functional properties of human embryonic stem cell-derived cardiomyocytes,” Annals of the New York Academy of Sciences, vol. 1047, pp. 66–75, 2005. View at Publisher · View at Google Scholar · View at Scopus
  107. O. Binah, K. Dolnikov, O. Sadan et al., “Functional and developmental properties of human embryonic stem cells-derived cardiomyocytes,” Journal of Electrocardiology, vol. 40, no. 6, pp. S192–S196, 2007. View at Publisher · View at Google Scholar · View at Scopus
  108. M. Brito-Martins, S. E. Harding, and N. N. Ali, “β1- and β2-adrenoceptor responses in cardiomyocytes derived from human embryonic stem cells: comparison with failing and non-failing adult human heart,” British Journal of Pharmacology, vol. 153, no. 4, pp. 751–759, 2008. View at Publisher · View at Google Scholar
  109. A. Kleger, T. Seufferlein, D. Malan et al., “Modulation of calcium-activated potassium channels induces cardiogenesis of pluripotent stem cells and enrichment of pacemaker-like cells,” Circulation, vol. 122, no. 18, pp. 1823–1836, 2010. View at Publisher · View at Google Scholar
  110. M. Ieda, J.-D. Fu, P. Delgado-Olguin et al., “Direct reprogramming of fibroblasts into functional cardiomyocytes by defined factors,” Cell, vol. 142, no. 3, pp. 375–386, 2010. View at Publisher · View at Google Scholar